1. Home
  2. PSNL vs PNI Comparison

PSNL vs PNI Comparison

Compare PSNL & PNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSNL
  • PNI
  • Stock Information
  • Founded
  • PSNL 2011
  • PNI 2002
  • Country
  • PSNL United States
  • PNI United States
  • Employees
  • PSNL N/A
  • PNI N/A
  • Industry
  • PSNL Medical Specialities
  • PNI Trusts Except Educational Religious and Charitable
  • Sector
  • PSNL Health Care
  • PNI Finance
  • Exchange
  • PSNL Nasdaq
  • PNI Nasdaq
  • Market Cap
  • PSNL 478.0M
  • PNI 77.2M
  • IPO Year
  • PSNL 2019
  • PNI N/A
  • Fundamental
  • Price
  • PSNL $5.87
  • PNI $6.94
  • Analyst Decision
  • PSNL Strong Buy
  • PNI
  • Analyst Count
  • PSNL 4
  • PNI 0
  • Target Price
  • PSNL $8.13
  • PNI N/A
  • AVG Volume (30 Days)
  • PSNL 880.7K
  • PNI 26.4K
  • Earning Date
  • PSNL 11-05-2025
  • PNI 01-01-0001
  • Dividend Yield
  • PSNL N/A
  • PNI 4.76%
  • EPS Growth
  • PSNL N/A
  • PNI N/A
  • EPS
  • PSNL N/A
  • PNI N/A
  • Revenue
  • PSNL $80,317,000.00
  • PNI N/A
  • Revenue This Year
  • PSNL N/A
  • PNI N/A
  • Revenue Next Year
  • PSNL $29.83
  • PNI N/A
  • P/E Ratio
  • PSNL N/A
  • PNI N/A
  • Revenue Growth
  • PSNL 0.36
  • PNI N/A
  • 52 Week Low
  • PSNL $2.83
  • PNI $6.03
  • 52 Week High
  • PSNL $7.79
  • PNI $7.89
  • Technical
  • Relative Strength Index (RSI)
  • PSNL 63.82
  • PNI 76.08
  • Support Level
  • PSNL $4.73
  • PNI $6.49
  • Resistance Level
  • PSNL $6.26
  • PNI $6.93
  • Average True Range (ATR)
  • PSNL 0.28
  • PNI 0.06
  • MACD
  • PSNL 0.16
  • PNI 0.04
  • Stochastic Oscillator
  • PSNL 77.85
  • PNI 97.56

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

About PNI Pimco New York Municipal Income Fund II of Beneficial Interest

PIMCO New York Municipal Income Fund II is a closed-end management investment company. Its investment objective is to seek to provide current income exempt from federal, New York State and New York City income tax. The fund portfolio of investments consists of investments in different sectors such as education, transportation, healthcare, and others.

Share on Social Networks: